Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis - Wikidata - awgldk - TriplyDB

Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis

Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis

http://www.wikidata.org/entity/Q35636947

about

Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.Preclinical rheumatoid arthritis (autoantibodies): an updated review Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis Modeling activation of inflammatory response system: a molecular-genetic neural network analysis.The difficulties of reproducing conventionally derived results through 500k-chip technology.Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives.The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.The role of interleukin 6 in the pathophysiology of rheumatoid arthritis Environmental and gene-environment interactions and risk of rheumatoid arthritis.Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis.Strategies to predict rheumatoid arthritis development in at-risk populations.Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.Early environmental exposure and the development of lupus.Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study Ambient air pollution exposures and risk of rheumatoid arthritis.Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)Evaluation of anti-inflammatory potential of the multidrug herbomineral formulation in male Wistar rats against rheumatoid arthritis.Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays.Can rheumatoid arthritis be prevented?ACPA and bone loss in rheumatoid arthritis.Defining populations at risk of rheumatoid arthritis: the first steps to prevention.Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders.Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.Association Between Serum Antibodies to Periodontal Bacteria and Rheumatoid Factor in the Third National Health and Nutrition Examination Survey.Evaluation of antinociceptive and antirheumatic activity of Grangea maderaspatana (L.) Poir. using experimental models.Anti-Arthritic Activity of Bartogenic Acid Isolated from Fruits of Barringtonia racemosa Roxb. (Lecythidaceae).Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.A prediction rule for the development of arthritis in seropositive arthralgia patients.The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.

P2860

Q22000849-EBBF756C-4447-49B0-82DE-0A293CAADDBA Q26863441-F90966CC-2F26-4A80-8461-842052174BF0 Q27014005-00D4B56C-FC59-48AB-98A2-50B0D49C5476 Q33333031-213A8162-D2DC-49B4-98ED-E24D0C5DF2A4 Q33519358-71E60A9A-DDA7-480E-B4F1-4D7939210270 Q33802181-EA12AB41-2566-484C-A2A2-4259746B866D Q33890221-5A250DD3-9BAE-411D-B3F3-B32396AB3303 Q33996319-3078838C-FD37-4EF5-8E27-D6549E52AC3D Q34159040-BF7810D7-6559-4C1F-AC2D-593E377EFECB Q34244089-BC83E0A0-8833-4A8E-8FA8-0AC1C367B64B Q34307377-60F013E6-1387-4B34-9058-9FBC7B5AA16D Q34907832-DF9BB4CA-87AC-449F-8B90-48EDF4085645 Q34917019-E9ED8378-D494-4246-9A22-98EBB3008B0E Q36059484-4C7E3EC9-EE58-4023-9140-854855CD71DE Q36110733-A174D14B-7630-4EFD-9078-A4D109447442 Q36166090-302E5C3B-178C-45F0-AC16-EA412A7BA9D8 Q36366153-18DB7FA5-A9D7-488C-AD23-D5A6DF15D2BE Q36396428-AC6BC9E2-E3D8-4467-A087-E96366116599 Q36677045-741C7912-0405-4CEB-83EC-D22DC1074F5A Q36844067-F71168A2-FE35-49EA-996C-FD6D953305E2 Q36859711-8D86D40F-EC3E-4D2F-94DE-48BBB40E63C0 Q37053019-22FDD898-FB65-47F6-9D6F-F761F315C988 Q37080148-D97F74FC-B7E4-46BB-B8FA-628708886A42 Q37273372-FA2EE523-B372-4B65-B104-4879B0676F29 Q37462533-43102E99-E84C-481A-AEC7-B60EAB9AAD8B Q37480830-B5D809A9-F3C5-4103-A8C4-924C8FC6B20F Q37538473-D54782F6-50F9-4ABD-A4B7-911F10428032 Q37589108-CC94BB1D-A03F-4503-98A9-4516DEDBB35C Q38129723-80DC318F-6E74-404E-AB40-E5D90D983197 Q38220638-48FB67F3-B9FC-41A3-9B5C-DA3D352D2F2F Q38854101-04391F24-852F-4FCD-A0C9-8675431584D9 Q38995539-B16B3390-2231-4925-9EB7-CCFA6336EECA Q39825098-B8DA383B-AF09-4180-8D4D-0B5B14D5021F Q41219280-2EBC00BC-30AC-4C3B-87DC-F9CAE9040F9A Q42011175-07759373-5659-43E9-BC16-8051CC7A7F8A Q42423867-D01197C9-AB47-49F8-BCF1-84835ED06C05 Q44071398-A81919E9-2F74-4457-B7F4-9B3EF336C322 Q44122281-6E65A69E-B71C-4E11-8C31-3E9370F3DE2C Q45807784-37D9D0BA-163C-4592-AB91-C274C891632B Q50308665-653DE018-E1C5-4886-BB49-BD7B0702733B

P2860

Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis

http://www.wikidata.org/entity/Q35636947

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@ast

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@en

type

label

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@ast

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@en

prefLabel

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@ast

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@en

P1433

Q35636947-F67559A6-FF68-408D-9E30-32DF6AD29CFA

P1476

Q35636947-347632DE-E05D-4BC2-AE40-28AAF1E752CD

P2093

Q35636947-1B2B628A-1C77-4F26-B040-4A7B6BC642ED

Q35636947-228A3534-4612-43E8-B321-852968786FDA

Q35636947-31B2EB57-D9ED-4126-B2D3-5359FB737A89

Q35636947-6F0C84AD-D06F-485F-A0DF-9BF83C206663

Q35636947-719CBB16-7265-439F-8639-1F4814D04C63

Q35636947-99853DE7-B1B1-4230-BDC7-2647B9532C4F

Q35636947-C7C6B4E6-D7C4-4B44-B135-2B563AC2DDFE

Q35636947-CBFDD104-F947-44BB-8A3A-677456C878CF

Q35636947-ED6B0314-E1C4-4832-B843-351170FD6C5B

P2860

Q35636947-283A2486-788F-4F4E-ADFC-C8F1A73909C1

Q35636947-3B6AE4C0-CCB7-4D24-A3C7-BD3783D6115A

Q35636947-7382AEA5-1224-4237-A7FD-19C2412410AE

Q35636947-CB4D9268-5D93-4404-83C4-B33159D05ABF

P304

Q35636947-B345C6E3-346F-4C9B-B847-EA722465F045

P31

Q35636947-F00A23D9-C7A6-44E5-AF54-9D35A4C83C4A

Q35636947-ff381e54-6758-4fd5-96c3-8d3aabf5d0ab

P356

Q35636947-C6C1E9AB-4BF1-4740-9A8B-9BBC1BC70C33

P407

Q35636947-AF8303D2-0C24-476C-8766-78A828DD385C

P433

Q35636947-59DFAE58-6D9B-4F43-B4FA-816E612A1912

P478

Q35636947-AD47F5E8-E858-40DD-B7BD-8DA60F0C08EE

P577

Q35636947-E9C4FC1B-906C-4676-A5BB-7985DCE3767B

P5875

Q35636947-98D7A1CF-BFC8-418A-85C7-F8D8DBBCE10C

P698

Q35636947-97EC52C3-085E-4E57-8258-82677F3A8DAB

P921

Q35636947-129C69A6-1AB1-4620-AD0C-063CD9C73CFE

P932

Q35636947-46C370F0-7BF6-4946-AF61-540D22B52557

P356

ARD.2005.040659

P1433

Annals of the Rheumatic Diseases

P1476

Simultaneous development of ac ...... eclinical rheumatoid arthritis

@en

P2093

B A C Dijkmans

http://www.w3.org/2001/XMLSchema#string

D van Schaardenburg

http://www.w3.org/2001/XMLSchema#string

H W Reesink

http://www.w3.org/2001/XMLSchema#string

I E van der Horst-Bruinsma

http://www.w3.org/2001/XMLSchema#string

J W R Twisk

http://www.w3.org/2001/XMLSchema#string

M H M T de Koning

http://www.w3.org/2001/XMLSchema#string

M M J Nielen

http://www.w3.org/2001/XMLSchema#string

M R Habibuw

http://www.w3.org/2001/XMLSchema#string

R J van de Stadt

http://www.w3.org/2001/XMLSchema#string

P2860

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.

P304

535-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2005.040659

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7681187

http://www.w3.org/2001/XMLSchema#string

P698

16079166

http://www.w3.org/2001/XMLSchema#string

P921

P932

1798080

http://www.w3.org/2001/XMLSchema#string